Scinovex
review Open AccessTop 1% cited

Advances in therapeutic applications of extracellular vesicles

Science Translational Medicine · 2019 · Vol. 11(492)
Oscar P. B. WiklanderMeadhbh Á. BrennanJan LötvallXandra O. BreakefieldSamir EL Andaloussi

Abstract

Extracellular vesicles (EVs) are nanometer-sized, lipid membrane-enclosed vesicles secreted by most, if not all, cells and contain lipids, proteins, and various nucleic acid species of the source cell. EVs act as important mediators of intercellular communication that influence both physiological and pathological conditions. Given their ability to transfer bioactive components and surmount biological barriers, EVs are increasingly being explored as potential therapeutic agents. EVs can potentiate tissue regeneration, participate in immune modulation, and function as potential alternatives to stem cell therapy, and bioengineered EVs can act as delivery vehicles for therapeutic agents. Here, we cover recent approaches and advances of EV-based therapies.

Extracellular vesicles in diseaseMicroRNA in disease regulationRNA Interference and Gene DeliveryExtracellular vesiclesExtracellular vesicleExtracellularVesicleCell biologyMicrovesiclesChemistryBiologyBiochemistrymicroRNA

MeSH terms

Extracellular VesiclesAnimalsDiseaseHumansImmunotherapyDrug Delivery SystemsBioengineering

Funding

  • Swedish Cancer Foundation
  • Svenska Forskningsrådet Formas
Citations
983
FWCI
41.46
field-weighted impact
References
183
Percentile
100%
vs. same field & year
Citations per year
Cited by
Advances in oligonucleotide drug delivery
Nature Reviews Drug Discovery · 2020 · 1,897 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.